Evelo Biosciences Price Prediction

EVLODelisted Stock  USD 8.23  2.68  24.56%   
As of today, The relative strength index (RSI) of Evelo Biosciences' share price is at 52 suggesting that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Evelo Biosciences, making its price go up or down.

Oversold Vs Overbought

52

 
Oversold
 
Overbought
The successful prediction of Evelo Biosciences' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Evelo Biosciences, which may create opportunities for some arbitrage if properly timed.
Using Evelo Biosciences hype-based prediction, you can estimate the value of Evelo Biosciences from the perspective of Evelo Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evelo Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Evelo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Evelo Biosciences after-hype prediction price

    
  USD 8.23  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Intrinsic
Valuation
LowRealHigh
6.326.329.05
Details
Naive
Forecast
LowNextHigh
11.4511.4511.45
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.418.8812.35
Details

Evelo Biosciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Evelo Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evelo Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Evelo Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Evelo Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Evelo Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evelo Biosciences' historical news coverage. Evelo Biosciences' after-hype downside and upside margins for the prediction period are 8.23 and 8.23, respectively. We have considered Evelo Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
8.23
8.23
After-hype Price
8.23
Upside
Evelo Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Evelo Biosciences is based on 3 months time horizon.

Evelo Biosciences Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Evelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evelo Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evelo Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
15 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
8.23
8.23
0.00 
0.00  
Notes

Evelo Biosciences Hype Timeline

Evelo Biosciences is currently traded for 8.23. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Evelo is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Evelo Biosciences is about 0.0%, with the expected price after the next announcement by competition of 8.23. About 83.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 15.64. Evelo Biosciences had not issued any dividends in recent years. The entity had 1:20 split on the 30th of June 2023. Given the investment horizon of 90 days the next expected press release will be in a few days.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Evelo Biosciences Related Hype Analysis

Having access to credible news sources related to Evelo Biosciences' direct competition is more important than ever and may enhance your ability to predict Evelo Biosciences' future price movements. Getting to know how Evelo Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evelo Biosciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
APTXAptinyx 0.02 5 per month 0.00 (0.17) 12.50 (16.67) 75.72 
MGTAMagenta Therapeutics(0.02)2 per month 3.40 (0.0002) 5.88 (4.29) 16.99 
ALRNAileron Therapeutics(0.16)7 per month 4.61  0.04  8.06 (7.99) 41.47 
ABVCABVC Biopharma 0.02 2 per month 0.00 (0.08) 7.25 (9.09) 35.84 
SRZNSurrozen(0.75)5 per month 4.87  0.03  16.74 (7.91) 33.59 
PCSAProcessa Pharmaceuticals 0.03 3 per month 0.00 (0.16) 6.20 (5.34) 20.99 
NEXINeximmune 0.00 0 per month 0.00 (0.04) 5.90 (9.00) 94.30 
TPSTTempest Therapeutics(0.47)4 per month 0.00 (0.1) 6.38 (8.53) 29.55 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.08) 4.05 (3.53) 27.84 
CTMXCytomX Therapeutics(0.06)9 per month 0.00 (0.08) 6.25 (5.22) 20.61 
ASMBAssembly Biosciences 0.29 7 per month 4.39  0  8.79 (5.34) 21.34 
TILInstil Bio(1.12)8 per month 6.82  0.13  20.63 (10.89) 105.83 
NUVBNuvation Bio 0.21 8 per month 4.52 (0.02) 9.48 (8.36) 21.30 
GBIOGeneration Bio Co(0.01)5 per month 0.00 (0.18) 9.35 (8.20) 25.48 
KRONKronos Bio 0.01 8 per month 3.32 (0.04) 5.75 (6.25) 16.20 
ERASErasca Inc(0.02)6 per month 3.55  0.01  7.34 (5.19) 17.38 
CCCCC4 Therapeutics(0.35)10 per month 0.00 (0.11) 8.59 (7.98) 23.66 
EWTXEdgewise Therapeutics 1.60 10 per month 2.79  0.11  6.65 (4.70) 61.02 
WINTWindtree Therapeutics(0.04)7 per month 0.00 (0.27) 12.00 (18.48) 60.67 
DRMADermata Therapeutics 0.04 3 per month 0.00 (0.06) 9.22 (8.05) 69.06 
ENSCEnsysce Biosciences 0.00 7 per month 10.26  0.05  27.27 (20.00) 184.26 
PBLAPanbela Therapeutics 0.00 0 per month 0.00 (0.21) 10.70 (17.30) 88.58 
BXRXBaudax Bio 0.53 2 per month 0.00 (0.03) 8.24 (15.31) 141.24 

Evelo Biosciences Additional Predictive Modules

Most predictive techniques to examine Evelo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evelo using various technical indicators. When you analyze Evelo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Evelo Biosciences Predictive Indicators

The successful prediction of Evelo Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evelo Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evelo Biosciences based on analysis of Evelo Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evelo Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evelo Biosciences's related companies.

Story Coverage note for Evelo Biosciences

The number of cover stories for Evelo Biosciences depends on current market conditions and Evelo Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Evelo Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Evelo Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Evelo Biosciences Short Properties

Evelo Biosciences' future price predictability will typically decrease when Evelo Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Evelo Biosciences often depends not only on the future outlook of the potential Evelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.4 M
Cash And Short Term Investments47.9 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Evelo Pink Sheet

If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
CEOs Directory
Screen CEOs from public companies around the world